vatalanib has been researched along with Bone Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bachelier, R; Clézardin, P; Confavreux, CB; Croset, M; Goehrig, D; Peyruchaud, O; van der Pluijm, G | 1 |
| Alsop, DC; De Bazelaire, C; Duhamel, G; George, D; Michaelson, MD; Rofsky, NM | 1 |
| Dai, J; Keller, ET; Keller, JM; Kitagawa, Y; Nor, J; Yao, Z; Zhang, J | 1 |
1 trial(s) available for vatalanib and Bone Cancer
| Article | Year |
|---|---|
Arterial spin labeling blood flow magnetic resonance imaging for the characterization of metastatic renal cell carcinoma(1).
Topics: Antineoplastic Agents; Bone Neoplasms; Carcinoma, Renal Cell; Cohort Studies; Contrast Media; Feasibility Studies; Female; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Phthalazines; Protein Kinase Inhibitors; Pyridines; Receptors, Vascular Endothelial Growth Factor; Regional Blood Flow; Spin Labels | 2005 |
2 other study(ies) available for vatalanib and Bone Cancer
| Article | Year |
|---|---|
Combination of anti-angiogenic therapies reduces osteolysis and tumor burden in experimental breast cancer bone metastasis.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bone Neoplasms; Breast Neoplasms; Female; Human Umbilical Vein Endothelial Cells; Humans; Immunocompromised Host; Mice; Mice, Inbred C3H; Osteolysis; Phthalazines; Pregnancy; Pyridines; Receptors, Vascular Endothelial Growth Factor; RNA, Small Interfering; Transfection; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2014 |
Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity.
Topics: Alkaline Phosphatase; Animals; Binding Sites; Bone Neoplasms; Cell Line, Tumor; Humans; Male; Mice; Mice, SCID; Osteoblasts; Osteocalcin; Phthalazines; Prostatic Neoplasms; Protein Kinase Inhibitors; Pyridines; RNA, Messenger; Signal Transduction; Vascular Endothelial Growth Factor A | 2005 |